1153 related articles for article (PubMed ID: 35608903)
1. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Memantine for dementia.
McShane R; Westby MJ; Roberts E; Minakaran N; Schneider L; Farrimond LE; Maayan N; Ware J; Debarros J
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD003154. PubMed ID: 30891742
[TBL] [Abstract][Full Text] [Related]
5. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitors for Alzheimer's disease.
Birks J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD005593. PubMed ID: 16437532
[TBL] [Abstract][Full Text] [Related]
8. Animal-assisted therapy for dementia.
Lai NM; Chang SMW; Ng SS; Tan SL; Chaiyakunapruk N; Stanaway F
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31763689
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids for the treatment of dementia.
Bosnjak Kuharic D; Markovic D; Brkovic T; Jeric Kegalj M; Rubic Z; Vuica Vukasovic A; Jeroncic A; Puljak L
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012820. PubMed ID: 34532852
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine for Alzheimer's disease.
Birks JS; Chong LY; Grimley Evans J
Cochrane Database Syst Rev; 2015 Sep; 9(9):CD001191. PubMed ID: 26393402
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Li Y; Hai S; Zhou Y; Dong BR
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
[TBL] [Abstract][Full Text] [Related]
14. Cognitive rehabilitation for people with mild to moderate dementia.
Kudlicka A; Martyr A; Bahar-Fuchs A; Sabates J; Woods B; Clare L
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013388. PubMed ID: 37389428
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
[TBL] [Abstract][Full Text] [Related]
16. Interventions for preventing falls in Parkinson's disease.
Allen NE; Canning CG; Almeida LRS; Bloem BR; Keus SH; Löfgren N; Nieuwboer A; Verheyden GS; Yamato TP; Sherrington C
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD011574. PubMed ID: 35665915
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase inhibitors for autistic spectrum disorders.
Ure A; Cox GR; Haslam R; Williams K
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013851. PubMed ID: 37267443
[TBL] [Abstract][Full Text] [Related]
18. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]